Orpea


The ESG mess aftermath costs dearly

21/09/22 -"Orpea’s latest communication foresaw lingering reputational risks, serious inflation effects (which seem hard to be recovered from the residents’ side in the short term) and additional ..."

Pages
61
Language
English
Published on
21/09/22
You may also be interested by these reports :
30/09/22
We have adjusted our 2022 EPS estimate downward further following the group’s H1 22 trading update, pointing out the underlying operating margin from ...

29/09/22
The group’s actual H1 results and H2 financial forecast remain consistent with the preliminary communication, as well as its limited ability to ...

28/09/22
Overall, Sonova remains our preferred hearing aids bet, largely banking on the potential benefits associated with newer and innovative offerings. ...

26/09/22
Considering the recent shift in US patient/consumer spending patterns i.e. delayed purchases – which could also impact other (mature) markets, ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO